KCNV1 | Potassium channel, subfamily V, member 1 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
TNR | Tenascin R | Predicted secreted proteins
| | | | | Tissue enriched |
C1orf61 | Chromosome 1 open reading frame 61 | | | | | | Tissue enriched |
FXYD7 | FXYD domain containing ion transport regulator 7 | Predicted membrane proteins
| | | | | Tissue enriched |
GPM6A | Glycoprotein M6A | Predicted membrane proteins
| | | | | Tissue enriched |
CACNG3 | Calcium channel, voltage-dependent, gamma subunit 3 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ATP6V1G2 | ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 | | | | | | Tissue enriched |
SYN1 | Synapsin I | Disease related genes Plasma proteins
| | | | | Tissue enriched |
VWC2L | Von Willebrand factor C domain containing protein 2-like | Predicted secreted proteins
| | | | | Tissue enriched |
HPCA | Hippocalcin | Plasma proteins
| | | | | Tissue enriched |
HTR2C | 5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
KCNA1 | Potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia) | Disease related genes FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
C11orf87 | Chromosome 11 open reading frame 87 | Predicted membrane proteins
| | | | | Tissue enriched |
KIF5A | Kinesin family member 5A | Disease related genes
| | | | | Tissue enriched |
MOBP | Myelin-associated oligodendrocyte basic protein | | | | | | Tissue enriched |
NTSR2 | Neurotensin receptor 2 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
PACSIN1 | Protein kinase C and casein kinase substrate in neurons 1 | Plasma proteins
| | | | | Tissue enriched |
SEPT3 | Septin 3 | | | | | | Tissue enriched |
TRIM67 | Tripartite motif containing 67 | Cytoskeleton related proteins
| | | | | Tissue enriched |
GPR26 | G protein-coupled receptor 26 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
LRRTM4 | Leucine rich repeat transmembrane neuronal 4 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
NPTX1 | Neuronal pentraxin I | Predicted secreted proteins
| | | | | Tissue enriched |
FAM19A1 | Family with sequence similarity 19 (chemokine (C-C motif)-like), member A1 | Predicted secreted proteins
| | | | | Tissue enriched |
NKAIN2 | Na+/K+ transporting ATPase interacting 2 | Disease related genes Predicted membrane proteins
| | | | | Tissue enriched |
RTN1 | Reticulon 1 | Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
SLC17A6 | Solute carrier family 17 (vesicular glutamate transporter), member 6 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SNAP25 | Synaptosomal-associated protein, 25kDa | FDA approved drug targets Transporters
| | | | | Tissue enriched |
MBP | Myelin basic protein | Candidate cardiovascular disease genes Disease related genes Plasma proteins
| | | | | Tissue enriched |
NRXN1 | Neurexin 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
SLC4A10 | Solute carrier family 4, sodium bicarbonate transporter, member 10 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
STMN4 | Stathmin-like 4 | | | | | | Tissue enriched |
TMEM151A | Transmembrane protein 151A | Predicted membrane proteins
| | | | | Tissue enriched |
BCAN | Brevican | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CNTNAP4 | Contactin associated protein-like 4 | Predicted membrane proteins
| | | | | Tissue enriched |
SCN2A | Sodium channel, voltage-gated, type II, alpha subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enriched |
STX1B | Syntaxin 1B | Predicted membrane proteins
| | | | | Tissue enriched |
GABRB2 | Gamma-aminobutyric acid (GABA) A receptor, beta 2 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
HRH3 | Histamine receptor H3 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
OPCML | Opioid binding protein/cell adhesion molecule-like | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SLC1A2 | Solute carrier family 1 (glial high affinity glutamate transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
APC2 | Adenomatosis polyposis coli 2 | | | | | | Tissue enriched |
CASKIN1 | CASK interacting protein 1 | Plasma proteins
| | | | | Tissue enriched |
DIRAS2 | DIRAS family, GTP-binding RAS-like 2 | | | | | | Tissue enriched |
DKFZP761K2322 | HCG1990367; Putative uncharacterized protein DKFZp761K2322; Putative uncharacterized protein FLJ30594; Uncharacterized protein; cDNA FLJ30594 fis, clone BRAWH2008903 | | | | | | Tissue enriched |
FRMPD4 | FERM and PDZ domain containing 4 | Cytoskeleton related proteins
| | | | | Tissue enriched |
GABBR2 | Gamma-aminobutyric acid (GABA) B receptor, 2 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enriched |
GABRG1 | Gamma-aminobutyric acid (GABA) A receptor, gamma 1 | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
GDAP1L1 | Ganglioside induced differentiation associated protein 1-like 1 | Predicted membrane proteins
| | | | | Tissue enriched |
HAPLN2 | Hyaluronan and proteoglycan link protein 2 | Predicted secreted proteins
| | | | | Tissue enriched |
JPH3 | Junctophilin 3 | Disease related genes Predicted membrane proteins
| | | | | Tissue enriched |